Neuroprotective Activity of 5-ethoxy-2-ethylthiobenzimidazole (Etomerzol) and 2-ethylthiobenzimidazole (Bemitil) in a Model of Middle Cerebral Artery Occlusion
Introduction. Cerebrovascular diseases (CVD) are one of the most pressing medical and social problems due to the high rate of mortality and disability. Stroke is the leading cause of CVD. About 15 million strokes are registered annually in the world according to the World Federation of Neurological...
Saved in:
| Main Authors: | E. Yu. Zavarina, E. K. Krasova, I. A. Titovich, A. N. Kimaev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-12-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1604 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of the Composition and Technology of Orally Dispersed Tablets Based on Ethylthiobenzimidazole Fumarate
by: I. D. Kasymov, et al.
Published: (2022-11-01) -
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USA
by: Sophia Woodson, et al.
Published: (2025-06-01) -
Repurposed Nrf2 activator dimethyl fumarate rescues muscle inflammation and fibrosis in an aggravated mdx mouse model of Duchenne muscular dystrophy
by: Stephanie Kourakis, et al.
Published: (2025-07-01) -
Concurrent targeting of glycolysis in bacteria and host cell inflammation in septic arthritis
by: Hyuk‐Kwon Kwon, et al.
Published: (2022-11-01) -
Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy
by: Pablo Ranea‐Robles, et al.
Published: (2018-07-01)